Human serum amyloid A has cytokine-like properties

Scandinavian Journal of Immunology

Volumn 48, Issue 4, 1998, Pages 410-418

  Patel, H ^a   Fellowes, R ^a   Coade, S ^a   Woo, P ^a  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; HIGH DENSITY LIPOPROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; MESSENGER RNA; SERUM AMYLOID A; TUMOR NECROSIS FACTOR ALPHA;

ACUTE PHASE RESPONSE; ARTICLE; GENE EXPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; INFLAMMATION; MONOCYTE; PLASMA; PRIORITY JOURNAL; PROTEIN ANALYSIS;

ANIMALS; CELLS, CULTURED; CYTOKINES; HUMANS; LIPOPROTEINS, HDL; MICE; MONOCYTES; POLYMERASE CHAIN REACTION; RECOMBINANT PROTEINS; RNA, MESSENGER; SERUM AMYLOID A PROTEIN;

EID: 0031754163     PISSN: 03009475     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-3083.1998.00394.x     Document Type: Article

References (40)

1. Kushner I, Maekiewicz A. The acute phase response: an overview. In: Mackiewicz A, Kushner I, Baumann H, eds. Acute Phase Proteins Molecular Biology, Biochemistry and Clinical Applications. London: CRC Press, 1993:3-20.
2. Husebekk A, Skogen B, Husby G, Marhaug G. Transformation of amyloid precursor SAA to protein AA and incorporation in amyloid fibrils in vivo. Scand J Immunol 1985;21:283-7.
3. Westermark GT, Sletten K, Grubb A, Westermark P. AA-amyloidosis. Tissue component-specific association of various protein AA subspecies and evidence of a fourth SAA gene product. Am J Pathol 1990;137:377-83.
4. Steinmetz A, Hocke G, Saile R, Puchois P, Fruchart JC. Influence of serum amyloid A on cholesterol esterification in human plasma. Biochim Biophys Acta 1989;1006:173-8.
5. Pruzanski W, de Beer FC, de Beer MC, Stefanski E, Vadas P. Serum amyloid A protein enhances the activity of secretory non-pancreatic phospholipase A2. Biochem J 1995;309:461-4.
6. Lindhorst E, Young D, Bagshaw W, Hyland M, Kisilevsky R. Acute inflammation, acute phase serum amyloid A and cholesterol metabolism in the mouse. Biochim Biophys Acta 1997;1339:143-54.
7. Banka CL, de Yuan T, de Beer MC, Kindy M, Curtiss LK, de Beer FC. Serum amyloid A (SAA): influence on HDL-mediated cellular cholesterol efflux. J Lipid Res 1995;36:1058-65.
8. Kisilevsky R, Subrahmanyan L. Serum amyloid A changes high density lipoprotein's cellular affinity. A clue to serum amyloid A's principal function. Lab Invest 1992;66:778-85.
9. Meek RL, Urieli Shoval S, Benditt EP. Expression of apolipoprotein serum amyloid A mRNA in human atherosclerotic lesions and cultured vascular cells: implications for serum amyloid A function. Proc Natl Acad Sci USA 1994;91:3186-90.
10. Urieli Shoval S, Meek RL, Hanson RH, Eriksen N, Benditt EP. Human serum amyloid A genes are expressed in monocyte/macrophage cell lines. Am J Pathol 1994;145:650-60.
11. Kumon Y, Sipe JD, Brinckerhoff CE, Schreiber BM. Regulation of extrahepatic apolipoprotein serum amyloid A (SAA) gene expression by interleukin-1 alpha alone: synthesis and secretion of SAA by cultured aortic smooth muscle cells. Scand J Immunol 1997;46:284-91.
12. Hardardottir I, Sipe J, Moser AH, Fielding CJ, Feingold KR, Grunfeld C. LPS and cytokines regulate extra hepatic mRNA levels of apolipoproteins during the acute phase response in Syrian hamsters. Biochim Biophys Acta 1997;1344:210-20.
13. Linke RP, Bock V, Valet G, Rothe G. Inhibition of the oxidative burst response of N-formyl peptide-stimulated neutrophils by serum amyloid-A protein. Biochem Biophys Res Commun 1991;176: 1100-5.
14. Badolato R, Wang JM, Murphy WJ, Lloyd AR, Michiel DF, Bausserman LL, Kelvin DJ, Oppenheim JJ. Serum amyloid A is a chemoattractant: induction of migration, adhesion, and tissue infiltration of monocytes and polymorphonuclear leukocytes. J Exp Med 1994;180:203-9.
15. Preciado Patt L, Pras M, Fridkin M. Binding of human serum amyloid A (hSAA) and its high-density lipoprotein3 complex (hSAA-HDL3) to human neutrophils. Possible implication to the function of a protein of an unknown physiological role. Int J Pept Protein Res 1996;48:503-13.
16. Badolato R, Johnston JA, Wang JM, McVicar D, Xu LL, Oppenheim JJ, Kelvin DJ. Serum amyloid A induces calcium mobilization and chemotaxis of human monocytes by activating a pertussis toxin-sensitive signaling pathway. J Immunol 1995;155:4004-10.
17. Xu L, Badolato R, Murphy WJ, Longo DL, Anver M, Hale S, Oppenheim JJ, Wang JM. A novel biologic function of serum amyloid A. Induction of T lymphocyte migration and adhesion. J Immunol 1995;155:1184-90.
18. Liang JS, Schreiber BM, Salmona M, Phillip G, Gonnerman WA, de Beer FC, Sipe JD. Amino terminal region of acute phase, but not constitutive, serum amyloid A (SAA) specificially binds and transports cholesterol into aortic smooth muscle and HepG2 cells. J Lipid Res 1996;37:2109-16.
19. Jarstrand C, Holmquist L, Wiernik A, Akerlund B, Carlson LA. Influence of human plasma high density lipoproteins from septic patients on different functions of normal human neutrophils. J Clin Lab Immunol 1990;33:69-73.
20. Zimlichman S, Danon A, Nathan I, Mozes G, Shainkin Kestenbaum R. Serum amyloid A, an acute phase protein, inhibits platelet activation. J Lab Clin Med 1990;116:180-6.
21. 2-82 on platelet aggregation. In: Natvig J, Forre O, Husby G et al. eds. Amyloid and Amyloidosis. Dordrecht: Kluwer Academic Publishers, 1990: 129-32.
22. Aldo Benson MA, Benson MD. SAA suppression of immune response in vitro: evidence for an effect on T cell-macrophage interaction. J Immunol 1982;128:2390-2.
23. Benson MD, Aldo Benson M. Effect of purified protein SAA on immune response in vitro: mechanisms of suppression. J Immunol 1979;122:2077-82.
24. Peristeris P, Gaspar A, Gros P, Laurent P, Bernon H, Bienvenu J. Effects of serum amyloid A protein on lymphocytes, HeLa, and MRC5 cells in culture. Biochem Cell Biol 1989;67:365-70.
25. Shainkin-Kestenbaum R, Berlyne G, Zimlichman S, Sorin HR, Nyska M, Danon A. Acute phase protein, serum amyloid A, inhibits IL-1- and TNF-induced fever and hypothalamic PGE2 in mice. Scand J Immunol 1991;34:179-83.
26. Ballou SP, Lozanski G. Induction of inflammatory cytokine release from cultured human monocytes by C-reactive protein. Cytokine 1992;4:361-8.
27. Mitchell TI, Coon CI, Brinckerhoff CE. Serum amyloid A (SAA3) produced by rabbit synovial fibroblasts treated with phorbol esters or interleukin 1 induces synthesis of collagenase and is neutralized with specific antiserum. J Clin Invest 1991;87:1177-85.
28. Strissel KJ, Girard MT, West-Mays J et al. Role of serum amyloid A as an intermediate in the IL-1 and PMA-stimulated signaling pathways regulating expression of rabbit fibroblast collagenase. Expt Cell Res 1997;237:275-87.
29. Patel H, Bramall J, Waters H, de Beer MC, Woo P. Expression of recombinant human serum amyloid A in mammalian cells and demonstration of the region necessary for high-density lipoprotein binding and amyloid fibril formation by site-directed mutagenesis. Biochem J 1996;318:1041-9.
30. Sipe JD, Colten HR, Goldberger G et al. Human serum amyloid A (SAA): biosynthesis and postsynthetic processing of preSAA and structural variants defined by complementary DNA. Biochemistry 1985;24:2931-6.
31. Strachan AF, Brandt WF, Woo P et al. Human serum amyloid A protein. The assignment of the six major isoforms to three published gene sequences and evidence for two genetic loci. J Biol Chem 1989;264:18368-73.
32. Hazenburg BPC, Limburg PC, Bijzet J, Van Rijswijk MH. Monoclonal antibody based ELISA for human SAA. In: Natvig J, Forre O, Husby G et al., eds. Amyloid and Amyloidosis. Dordrecht: Kluwer Academic Publishers, 1990: 898-901.
33. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Analyt Biochem 1987;162:156-9.
34. Wang AM, Doyle MV, Mark DF. Quantitation mRNA by polymerase chain reaction. Proc Natl Acad Sci USA 1989;86:9717-21.
35. Brenner C, Daniel SL, Adler R. Cytokine MAPPing: observation and quantification of cytokine mRNA in small numbers of cells using the PCR. In: Balkwin FR, ed. Cytokines a Practical Approach. Oxford: IRL Press, 1991: 51-9.
36. Gilliland G, Perrin S, Franklin B. Competitive PCR for quantitation of mRNA. In: Michael IA, Gelfand DH, Sninskym JJ, White TJ, eds. PCR Protocols, a Guide to Methods and Applications. London: Academic Press, 1990: 60-9.
37. Bouaboula M, Legoux P, Pessegue B et al. Standardization of mRNA titration using a polymerase chain reaction method involving co-amplification with a multispecific internal control. J Biol Chem 1992;267:21830-8.
38. Taktak YS, Selkirk S, Bristow AF, Carpenter A, Ball C, Rafferty B, Poole S. Assay of pyrogens by interleukin-6 release from monocytic cell lines. J Pharm Pharmacol 1991;43:578-82.
39. Schumann RR, Leong SR, Flaggs GW, Gray PW, Wright SD, Mathison JC, Tobias PS, Ulevitch RJ. Structure and function of lipopolysaccharide binding protein. Science 1990;249:1429-31.
40. Heumann D, Gallay P, Barras C, Zaech P, Ulevitch RJ, Tobias PS, Glauser MP, Baumgartner JD. Control of lipopolysaccharide (LPS) binding and LPS-induced tumor necrosis factor secretion in human peripheral blood monocytes. J Immunol 1992;148:3505-12.